UL Prospector
Prospector

IRSI Patch Test

Evaluating the occurrence of allergic or irritative responses by contacting products with the skin in maximized protocols is an excellent way to assess the safety of topical products. The tests include compatibility, potential irritation, clinical testing, safety testing, photoallergy, phototoxicity, primary irritation, HRIPT, cumulative irritation, patch test, Human Repeat Insult Patch Test, non-comedogenic, non-acnegenic, and hypoallergenic.

Company

International Research Services, Inc. (IRSI) is a privately held clinical research company founded in 1977 that serves the cosmetic and pharmaceutical industries.

Specializing in dermatological safety and efficacy testing, IRSI is a leader in biophysical instrumental analysis of the effects of test products on human skin conditions. For over 40 years of history, IRSI has become a reference in the development and conduct of clinical tests for products from different markets, such as pharmaceutical, cosmetic, hygiene, food and nutrition. In partnership with Allergisa, a Brazilian company with over 25 years of experience in these segments, the tests are carried out within the strictest standards of safety, which guarantees the credibility of the products that will reach people's homes.

Company Documents

The information presented here was acquired by UL from the producer of the product or material or original information provider. However, UL assumes no responsibility or liability for the accuracy of the information contained on this website and strongly encourages that upon final product or material selection information is validated with the manufacturer. This website provides links to other websites owned by third parties. The content of such third party sites is not within our control, and we cannot and will not take responsibility for the information or content.

International Research Services, Inc. (IRSI) makes their documentation available in the regions indicated below: